AI Article Synopsis
- Renal oncocytoma is a rare tumor known for distinct but not exclusive features, making diagnosis challenging.
- Percutaneous biopsy is a safe way to diagnose it, but differentiating it from other tumors may require advanced methods that aren't always available.
- Surgical treatment is often the first option or can be used after monitoring, with management decisions influenced by factors like tumor size, growth rate, and patient health status.
Article Abstract
Renal oncocytoma is an uncommon tumor that exhibits numerous features which are characteristic but not necessarily unique. Percutaneous biopsy is a safe method of diagnosis. However, differentiation from other tumor subtypes often requires sophisticated analysis and is not universally feasible. This is why, surgical management can be considered as a first-line treatment or after surveillance. Potential triggers for change in management are: tumor size >3 cm, stage progression, kinetics of size progression (>5 mm/y), and clinical change in patient or tumor factors. Long-term follow-up data are lacking and greater centralization should be considered to reach adequate management.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.urology.2020.05.047 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!